We’ve all grown up in househ o l d s wh i ch have Haldi doodh, although these days I hear its called ‘Turmeric Milk’ or the surprisingly romantic ‘Golden Latte’. Well this ‘golden latte’ touted as a wonder food, good for rejuvenation, and skin health and healing, and being called as an allrounder anti-inflammatory, has been around, at least for us Indians for thousands of years as ‘Haldi doodh’. I remember wrinkling up my nose and refusing to have it, when my mother would give it to me.
Be that as it may, the west seems to have finally woken up to ayurveda, or the ancient science of plant derived medicine. Yoga and alternative medicine, including pranic healing, reiki etc have suddenly had a resurgence in the west, and we Indians have suddenly become aware of our legacy, created thousands of years ago, which today with modern science and testing is being proved to be as effective if not more in a wide variety of ailments and diseases. Little did we realise, that the often foul tasting ‘kadha’ we were made to drink by our mothers, is actually a legacy and heritage we have, which has been thousands of year’s in the making. I have read that Indian medicine was so advanced that we actually performed rhinoplasty’s, often called a ‘Nose job’ in today’s language. It is absolutely clear, that if our doctors and healers were performing complicated surgeries and procedures thousands of years ago, they would necessarily have the know how of things like antibiotics, or anti coagulants. Surprisingly, these are discoveries that can only be traced back about a 100-150 years in western medicinal sciences.
India is known for its traditional medicinal systems like Ayurveda, Siddha and Unani source of which can be traced back to the ancient Vedas and other scriptures. The ayurvedic concept emerged and developed in India between 2500 and 500 BC. Ayurveda means “science of life” or “true knowledge of life”, since the Indian system of health care was centered around views of man and his illness. Being a tropical country, we Indians are naturally blessed with diverse flora, that are used in traditional medical treatments. In India, approximately 70percent of rural population depends on the traditional Ayurvedic system of medicine. In the Western countries, todayapproximately 40per cent of people have reposed faith in herbal and ayurvedic medicines for the treatment of various diseases. India is a mega-diverse country which harbours 7-8% of all recorded species, including over 45,000 species of plants and 91,000 species of animals. Of the 34 global biodiversity hotspots, four are present in India, represented by the Himalaya, the Western Ghats, the NorthEast, and the Nicobar Islands. Further, India is the largest producer of medicinal plants and the traditional medicinal systems found under Ayurveda, Siddha and Unani.
With a view to bring about an organised development of systems and standardise the mode of treatment by the practitioners of these systems, legislations have been framed by both the State Governments as well as the Central Government. The legislative field for framing legislation on these aspects is relatable to Schedule VII List III Entry 26 of the Constitution of India.
In Kerala Ayurveda Paramparya Vaidya Forum v. State of Kerala, (2018) 6 SCC 648 the issue under consideration before the Supreme Court was whether the persons who do not fulfil the prescribed qualification and are not duly registered under the relevant statute, be permitted to practice “Paramparya Vaidyas”. The Supreme Court after considering the eligibility criteria laid down in the Central law and also under the State laws concluded that the right to practise any profession or to carry on any occupation, trade or business is no doubt a fundamental right guaranteed under the Constitution but that right is subject to any law relating to the professional or technical qualification necessary for practising any profession or carrying on any occupation or trade or business.
This judgment was landmark, because it highlighted that our traditional medicine systems, are an important part of our heritage and that they cannot be treated as ‘not serious medicine’ or ‘magical remedies’. The judgment validated the fact that traditional medicine as found in the subcontinent of India, is medicine and needs to be studied and qualified for, just as much as western medicine, thus lending complete credence to the field.
Government of India, through its Ministry of AYUSH is responsible for policy formulation, development and implementation of programs for the growth, development and propagation of Ayurveda. After the change in government in 2014, a conscious decision was taken to upgrade the department and an independent Ministry of AYUSH with independent Minister and a mandate for systematic development in all spheres of Indian medicine was issued. It is a dedicated ministry created to uphold the standards and standardise procedures under the Indian System of medicine, which for so long had been neglected and been passed on to generations without truly understanding the value, in effect creating a situation, where it was considered second rate, or not trusted as much as its potential is.
Today there has been integration of AYUSH in the healthcare delivery system and national programs to ensure optimal use of the vast infrastructure of hospitals, dispensaries and physicians were focused in the policy. Through National Health Mission and National Rural Health Mission, an initiative to improve efficacy of Ayurveda has been undertaken. Resultantly, the public perception is getting inclined towards Ayurveda and development in AYUSH is observed. All this is poised to be achieved through the increase in potential of Ayurveda and optimum revival.
The educational system and professional practice of Ayurveda are controlled by the Central Council of Indian Medicine (CCIM), a statutory body set up under Indian Medicine Central Council (IMCC) Act, 1970. Ayurveda doctors with degree or equivalent qualifications are considered as recognized medical practitioners as per the schedules of Indian Medicine Central Council Act, 1970. The recognized qualifications for the purpose of registration and to engage in clinical practice of Ayurvedic Medicine are Bachelor of Ayurvedic Medicine and Surgery (BAMS) and MD/ MS (Ayurveda) master’s degrees in 22 specialties and equivalent qualifications.
One aspect of this resurgence of Ayurveda and the fact that today, we as a government, are taking it seriously was something i noticed when i represented the Ministry of AYUSH in Union of India Vs. Federation of Self-Financed Ayurvedic Colleges Punjab & Ors. Civil Appeal No. 603 of 2020, where the NEET exam was prescribed for students who wished to undertake graduate courses in Ayurvedic medicine. What surprised me was now seriously and vehemently, the department and the ministry took these admissions, vehement in their stand that they wanted and needed qualified and intelligent, hardworking students as doctors in traditional medicine field. The Supreme Court agreed.
On 17.10.2017, Prime Minister Modi in a speech laid stress on integrating Ayurveda, Yoga and other AYUSH systems into the public health care system, dedicated the All India Institute of Ayurveda situated at New Delhi to the nation. He also stressed on growing these herbs and medicines and said that the AYUSH ministry would provide the requisite knowhow.
Prime Minister Modi, during the lockdown due to COVID- 19 pandemic promoted practice of yoga amongst all including world leaders calling it a perfect antidote to self-isolation blues.
The fact that an ayurvedic formulation was given to Prince Charles when he was battling the Coronavirus is also telling of the nature and effectiveness of the Indian Medicine system as well the trust that is now being reposed in it.
According to the recent reports, Modi government is leading a study to determine whether the ayurvedic herb “Ashwagandha” could be an alternative to hydroxychloroquine (HCQ) as a potential COVID preventative. the study is being carried out by a group of scientists and researchers from Ministry of AYUSH, Ministry of Health and Family Welfare, the University Grants Commission (UGC) and the Indian Council of Medical Research (ICMR).
The Ministry of AYUSH is taking a huge step towards promotion and development of Ayurveda, however there are more to be done to mainstream Ayurveda and validate to make it acceptable world wide as a scientific system of healthcare to regain its glory.
Sr. Adv. Pinky Anand has served as head of All India Legal Cell of Bhartiya Janta Party (BJP). She has served as the Additional Solicitor General (ASG) of India.
The Daily Guardian is now on Telegram. Click here to join our channel (@thedailyguardian) and stay updated with the latest headlines.
For the latest news Download The Daily Guardian App.
CORONAVIRUS VACCINATION: TIME TO CONSIDER REMOVAL OF PATENT
The coronavirus vaccination process is well in progress, and life is creeping towards normalcy in a few nations. However, for certain nations, the pandemic is unleashing new degrees of decimation. India is wrestling with a cataclysmic second wave, reporting more than 20 million Covid cases and more than 250,000 deaths in the country amid boundless oxygen shortage.
The disparity in admittance to Covid-19 immunizations among rich and low-pay nations has gotten impossible disregarding. As indicated by UNICEF, 86% of all portions surrendered worldwide to 30 March were regulated to those in high-and upper-centre income nations, while only 1% of short of vaccine have been given to those on the planet’s most unfortunate. The Lower risk groups, the UK, the US and Israel are getting qualified for vaccination, while the vulnerable population somewhere else stay in danger of getting the infection.
As of now, eight types of vaccines are being utilized in general. No nation is utilizing every one of them however the more extravagant countries approach three or four, having put ahead of time requests. The vaccine producers are likewise ordinarily situated in these nations and have licenses that keep others from manufacturing and assembling them. The storing of vaccinations and medicines by well off nations, as the pandemic assaults monetarily hindered countries, has brought the issue of immunization licenses i.e. patent to the front.
At the global level, in October 2020, India and South Africa presented a unique proposition at the World Trade Organization (WTO) to defer drug organizations’ intellectual property (IP) rights for Covid-19 vaccines and medicines under the Trade-Related Aspects of Intellectual Property Rights settlement. The key idea behind this proposal was that the waiver would permit vaccine creators in more unfortunate nations to deliver vaccinations without confronting any legal activity from the organizations that hold licenses on the items. This specific proposal has recently gained steam, after US President Joe Biden reported his help, with trusts that this may make it simpler for some more nations to gain admittance to Covid-19 vaccinations.
This support by the US President has run into opposition from the drug business also known as Big Pharma and nations like Germany, stating this step won’t help in controlling the flare-up any time soon and will only hurt advancement and innovation. Biotechnology Innovation Organization president and CEO Michelle McMurry-Heath wrote in the Economist that this proposal of the patent being removed sabotages the very framework that created the life-saving science in any case and obliterates the motivator for organizations to face challenges to discover answers for the following wellbeing crisis.
The Indian government at home, however, isn’t just taking an alternate position, it has even requested that the Supreme Court not examine or notice the utilization of the state’s ability to abrogate protected intellectual property rights for fundamental medications or immunizations, stating that these could have “extreme and accidental antagonistic outcomes in the nation’s endeavors being made on a worldwide stage.” Whereas specialists believe that the Center’s remain against obligatory authorizing – which the Supreme Court had drifted as an apparatus it could use as a feature of its pandemic reaction – isn’t simply conflicting to its situation at worldwide forums, it could wind up endangering India’s endeavours to guarantee antibody value at the worldwide level. However, as the issues relating to urgent measures with respect to Covid-19 is sub-judice before the Hon’ble Supreme Court of India and different High Courts, therefore to be seen as to how the Hon’ble Courts deals with this issue.
For India to accomplish widespread vaccination, the prerequisite is of 1,878 million dosages — two portions each for 939 million adults in the country. As there are just two makers of the vaccination presently in the country— Bharat Biotech and Serum Institute of India — with their present creation limit at 80-90 million dosages each month, which could grow to 160 million portions by July 2021, there is an interest supply hole that should be spanned on a conflict balance.
To overcome this issue, there is a developing fuss to conjure the arrangement of ‘obligatory permitting’ under the Patents Act, 1970 as was done a decade ago for the treatment of cancer, malignancy.
The shortcoming of India’s vaccination program has gone to the front throughout the most recent month, as the fierce Covid-19 second wave detonated everywhere in the country. The shortage of vaccination in the country have been faced and the current speed would not permit India to arrive at herd immunity before the year’s over. Recently the Delhi Chief Minister Arvind Kejriwal has requested that the Center summon its forces to give compulsory licenses so immunization creation can be increase, determined to assist the states with vaccinating individuals throughout a more limited timeframe.
Patent rewards advancement by keeping contenders from essentially replicating an organization’s revelation and dispatching an adversary item. For patented product, the necessary permit arrangement permits the Indian government to concede fabricating rights to different makers without the assent of the proprietor, particularly during public crises. India’s first mandatory permit was conceded by the Indian Patent Office under the corrected 2005 Act to the Hyderabad-based medication maker Natco in 2017. It permitted the organization to produce and sell a comparable variant of Bayer’s medication Nexavar for the therapy of kidney malignant growth. The obligatory permit was conceded because the life-saving medication was not accessible at a moderate cost and Bayer had not made the medication to a sensible degree in India.
When an administration conjures a necessary permit, it awards consent to an individual to make or sell an innovation or item without looking for authorization from the patent holder. The topic of necessary authorizing in India includes two significant provisions under the Patents Act, 1970. The first is Section 92-as per this section the public authority can pronounce necessary permitting for any protected innovation amid a public or outrageous crisis. When an announcement is made, the regulator general of licenses can give licenses to any candidate. The patent holder will be paid an eminence fixed by the regulator general. Second is Section 100 of the Act-this section permits the Center or others to utilize the development or the innovation for governmental use whenever considered significant. This would permit Indian organizations to start fabricating while the eminence is being negotiated. On the off chance that the negotiation fizzle, it falls upon the High Court along with the jurisdiction to fix a sensible eminence.
Taking everything into account, specialists are proposing that through open permit strategy, antibody vaccine innovation could be moved from Bharat Biotech to different producers because the immunization was concocted with the help of the Indian Council of Medical Research (ICMR). Notwithstanding, comprehend that the ICMR’s help can measure up to banks giving asset backing to new companies. Accordingly, this doesn’t imply that one can remove the IPR of the immunization maker since Bharat Biotech is a separate company, not a part of the public authority. Indeed, even among various PSUs or government divisions, frequently lawful questions crop up because they are singular entities.
According to the current pandemic condition in the country, a humanitarian approach is the need of the hour and there probably won’t be any grievances or resistance if conventional standards are disregarded, regardless of whether at the degree of WTO or the homegrown front. On the other side, would it not be better that a reasonably balanced approach is embraced keeping in view the supply of vaccinations in the current times but also for the fulfilment of the same in the future?
WILL PHARMA COMPANIES SUFFER HUGE LOSSES?
At last, it comes down to the billion-dollar question. Pharma organizations have been contending that IPR and licenses are at the core of development, as is the speculation and cash that goes into it. Notwithstanding, will IPR waivers truly be uncalled for to enormous drugs and send them into misfortunes.
As opposed to what some are situating this tussle as a philosophical one around IPR, American Congresswoman Jan Schakowsky said during the TWN that it was basically about cash and benefits. “We are at battle with an infection, yet the thing we are seeing is making profits.”
It isn’t that an IPR waiver will leave pharma organizations poor the governments could take a gander at giving certain eminences to the trailblazer and originator organizations. For example, India gave its first mandatory permit permitted under its patent laws in 2012 for a malignant growth drug Nexavar made by Bayer.
Right now the patent situation is a “barbarous” one, with an “impetus structure adjusted to enormous drugs.” We need to move away from exclusive methods of licensing to a more open-source method of making medications.
The special cases being taken up today to guarantee all-inclusive vaccination is simply a transitory measure to pad individuals at the most for a very long time. According to clinical specialists, another portion or two of an improved rendition of the immunization will be along these lines should have been trailed by an antibody vaccination forever. Additionally, an immunization for kids under 18 years is still to be created.
It is similarly imperative to comprehend and not invalidate the way that the issue of licensed innovation rights was coordinated into the exchange plan. In the pre-WTO period, agricultural nations including India took into account the assembling of the protected item by different producers through an adjustment of the assembling interaction. Accordingly, these organizations likewise began trading medications hence making benefits. The TRIPS Agreement consequently got basic in settling exchange disagreements about protected innovation rights at a worldwide level. Consequently, nations like those in the European Union, which have bookings for loosening up IPRs, might be persuaded with the confirmation at WTO that the meds for fix and avoidance of the Covid would be utilized uniquely for homegrown use and not for trades.
In India, endeavours ought to be made for the move of innovation from organizations like Bharat Biotech to producers with the potential and required ability. In any case, brand value ought to be with Bharat Biotech with a kind of establishment plan. The organization’s R&D use ought to be remunerated through a proper evaluating strategy.
Though numerous legislatures across the world seem uncertain on whether to answer the call and on the off chance that they do — would it truly resolve the worldwide deficiency of vaccination and medicines, particularly in more unfortunate and low pay nations? Stand that the world takes on the issue will be a critical decision in fighting the battle against the coronavirus surge.
As of now, eight types of vaccines are being utilised in general. No nation is utilising every one of them, however the more extravagant countries approach three or four. The vaccine producers are likewise ordinarily situated in these nations and have licences that keep others from manufacturing and assembling them. The storing of vaccinations and medicines by well-off nations, as the pandemic assaults monetarily hindered countries, has brought the issue of immunisation licences i.e. patent to the front.
‘What are the key learnings that hospitality industry can take from current conditions?’
The world is currently battling with the unprecedented effects of the COVID-19. With the UN claiming it to be a crisis on humanity like never before, it has put our social fabric and cohesion under tremendous stress. In the face of this fatal virus, the economies worldwide have come to a standstill, making the travel restrictions and social distancing policies the new normal.
Impact of the Outbreak: The hospitality industry has taken a massive hit around the globe with occupancy rates dropping by 59% in US hotels alone. Significant declines are also forecasted in average daily rate (ADR), occupancy, demand, and revenue per available room (RevPAR) for 2020.
Current forecasts predict a deep economic contraction in the first half of the year, followed by a bounce-back in the latter half. However, there could also be a prolonged economic uncertainty that would resist a sharp bounce-back. As hotels counter this economic crisis, there will be a dire need to assess the business continuity and operational challenges, both for the short and long term, and understand the impact on Cash, Working Capital, and Profitability.
The severe situation had stalled travel plans for the majority of the people around the world but it is expected that hotel bookings will see a recovery after September 2020. However, it is also predicted that people will be more inclined towards traveling domestic rather than international. Thus, it is imperative for the hotels to be prepared before the business starts to ramp up and use this interim period as an opportunity to overhaul their legacy systems.
THE NEED OF THE HOUR
Regain Guest Confidence: The core of the relationship between any brand and its consumers is “the trust”, and thus recapturing guest confidence should be the primary step for any brand amidst this pandemic situation. At a time when consumer confidence is at an all-time low, communication will play the lead role in re-assuring the guests of the safe environments at different hotels. Also, within the hotel premises, the way hotels empower their guests with increasingly relevant and timely information, will also hold the key to future.
Revisit Hospitality Offerings:Hotels will need to review their existing service offerings to adapt to the “new normal” and provide a touch-free experience to their guests when they arrive at the property. To achieve this, Hotels will need a transformation in their daily operations to provide an experience that would ensure that both the guests and the hotel staff are in safe hands.
Employee Well Being: A turnaround is also expected in the hospitality industry at the employer level. The current working models need to be re-evaluated for efficiency with ‘employee wellbeing’ positioned higher than ever in the hotel’s priority list. Providing them with safety kits and eliminating the different touchpoints while serving the guests are the major needs of the hour.
Regulatory Compliances Liabilities: In this new environment, hotels need to adopt new practices to regulate the environment in which the business happens. Once the operations begin, stern measures on sanitation and hygiene will be very important and hotel properties will have to not just be aesthetically clean but also clinically clean. It will also be important to ensure that the mandatory regulatory guidelines such as social distancing are being followed at their properties
OPPORTUNITIES TO UPGRADE THE SKILL SET
Up-skill: Creating opportunities for hotel employees to add value to their skill-sets could build confidence in hotel companies, as layoffs can be expected by all major and minor hotel companies. Hyper-local hotels may see the largest number of layoffs due to the popular asset-light model, where large number of operating units, scattered across countries, could be written off all at once. This will bleed out a vast number of hospitality employees into an already difficult market. Individuals who can upgrade their skill sets by way of enrolling in speciality-specific courses could benefit greatly.
Re-skill:Offering routes such as ‘Recognition of Prior Learning’ opportunities to qualified hospitality front-line professionals could accelerate the process in re-skilling individuals, hence preparing them for roles in hotels and other hospitality-related operations in an environment where lean, yet skilled operations will be required.
Hygiene and sanitation remained a recurrent sub-theme throughout the responses, be it about foreseeable consumer behaviour or learnings for the industry and educators or trainers. The issue of hygiene has been well documented in tourism and hospitality literature. However, for a developing country like India that deals with issues like over-crowdedness and congestion, it is too serious a concern to be overlooked. where the researchers have speculated presence of SARS-COV-2 in human waste water becomes more consequential if not managed effectively. The seriousness of this issue can’t be emphasised enough and regardless of the type and size of the establishment, next crucial aspect that is likely to govern the survival would be the presence of standards of waste management and effective sanitation practices visible in all forms of hospitality operations.
Hospitality management must consider wearing masks mandatory until a sustained solution, for instance the most contemplated solution+COVID-19 vaccine, is achieved. Irrespective of type of operations, managers must consider creating dedicated task forces among employees to address hygiene issues and related training and awareness creation. Basing on the responses received it seems clear now that there is stark need of formulating national standards for tourism and hospitality enterprises, and their implementation and monitoring should be effectively carried out, failing that should invite relative penalties. The need of national standards also resonate with the recommendations made by authorities/researchers. One such standard practice could be mandatory temperature checking and its record keeping at the entry and exit points of work places and institutions.
The notion of retaining optimism and hopes of revival remained high. This was particularly visible with the responses pertaining to the manpower development. This viewpoint of the experts in tourism and hospitality may be attributable to their rich experiences, where they must have observed highs and lows in the industry. Although COVID-19 presents an unprecedented case before all the sectors, in that the reduced demand and revenues are obvious consequences, which can resonate with the previous crises that also had detrimental effects. However, in previous health (e.g. SARS, Swine Flu, MERS, and Ebola) or other sorts of crises (acts of terrorism, natural calamities) travellers mostly had alternatives at their disposal. This time the entire planet has been held hostage to this severe pandemic, which has brought an absolute halt on various activities, leisure sector being the prominent casualty. From the responses it is evident that alike educators, industry managers too didn’t shy away from highlighting the human resilience and seemed hopeful towards the eventual recovery, meanwhile reassuring individuals who have or intend to pursue careers in the industry.
Budgets and Capital Expenditure:Hotel owners should consider whether the existing rights of the owner in relation to the setting, approval and variation of budgets and decisions relating to capital expenditures are adequate or should be enhanced in order to give the owner greater say on decisions relating to expenditure that is considered necessary or desirable in light of Covid-19, for instance investments towards improving the health and safety components of the hotel.
This is extremely important from a hotel owner’s perspective because: (a) they have the obligation to fund the hotel’s working capital and capital expenditure requirements; and (b) the owner’s performance termination rights will typically be linked to the level of operating profit generated by the hotel operator relative to the budgeted operating profit. If the owner does not have adequate rights in respect to the setting of the budget and approval of variations from the budget and sufficient control over the budget process, then the operator could provide for a lower operating profit in the budget and thereby ensure that it does not fail the operating profit test (this is over and above a general exclusion which an operator may include for force majeure events).
Additionally, it would also be worthwhile to consider including a mechanism thereby the owner and operator have to mutually agree to adjust the budgets and capital expenditure for a specific period in the event of a force majeure event occurring and the operator should not have a unilateral right to make any such adjustments.
Compulsory Acquisition:During recent times, there have been instances where government authorities in certain countries have taken over hotels to use them as quarantine facilities for Covid-19 patients. While these instances may not be common, it gives rise to another scenario which may need to be covered in the condemnation provisions of hotel operating contracts. Further, as the hotel owner is unlikely to receive any substantial compensation from the government, the rights of an operator to receive any portion of the compensation received from the government should also be considered and re-examined and specific carve-outs may need to be agreed. Consideration should also be given to the hotel’s insurance policies and whether any conversion of use of the hotel into a quarantine or other medical facility may vitiate these insurance policies.
Public Health Emergency Obligations:Hotel operating contracts do not, usually, contain any provisions on: (a) the procedures to be followed by the parties; and (b) the rights and obligations of each party, in the event of a public health emergency occurring in the hotel (for example, a guest or staff testing positive for Covid-19). It is important that these gaps are filled to ensure that there is no ambiguity on the roles and responsibilities of the parties and thereby avoiding the blame-game.
HOTEL MANAGEMENT REQUIRES LIFELONG LEARNING
Albert Einstein said, “Once you stop learning, you start dying”, and the saying has never been truer than in the current context. Even if you were a seasoned hotel manager, the COVID-19 crisis has likely challenged all of your past experience and knowledge about the profession. In the face of uncertainty, hoteliers have had to relearn some of the key cornerstones of the industry, such as staffing and revenue management, both of which underwent major transformations because of COVID.
As a result, web traffic on hospitality-related educational platforms nearly doubled in the past few months. Instead of wallowing in self-pity, hoteliers understood that they needed to take action in order to adapt and save their business. In a great showing of courage and resilience, most of them took the matter into their own hands and kept looking for ways to survive amidst the plethora of constraining safety measures and lockdowns. This gave birth to new innovative strategies for hotels to generate revenue.
HOPING FOR A BEGINNING OF AN END
We can say that,
Post Covid19, organisations will surely redesign/reorganise their business models based on the loss handled and market conditions for the future. Workforce reduction is a possibility however smarter organisations may look at utilising the available workforce in newer roles as per the need of the business. Its (sic) important to understand that hospitality is all about human connections and people will be at the heart of everything we strategize.
COVID-19 is pushing the industry to manage, adapt, and respond to the uncertainty and risk associated with this global health incident. Managing the guests’ & employees’ safety and delivering as per guests’ expectations will not be considered a competitive advantage, but rather an industry imperative. Enterprises in the hospitality industry should partner with the right technology solutions providers to ensure a foolproof digital transformational strategy for the future.
RELAXATIONS PROVIDED UNDER GAS CYLINDERS RULES, 2016 TO FAST-TRACK IMPORTS
The relaxations in rules will fast-track approvals for imported cylinders and pressure vessels for storage and transportation of medical oxygen.
Government of India has reviewed the existing procedure for approval of global manufacturers for importing oxygen cylinders by Petroleum and Explosive Safety Organization (PESO). In view of the COVID pandemic, PESO shall not carry out physical inspection of global manufacturers’ production facilities before grant of such approval. Now, such approvals shall be granted online without any delay on submission of manufacturer’s particulars; ISO certificate of manufacturer; List of Cylinders their specifications, drawings & batch number; Hydro test certificate and Third-Party inspection Certificate. Every foreign manufacturer/ importer who wants to import oxygen cylinders is required to apply for import permission through PESO online system.
In view of emergent situation, procedures are relaxed and the following process is to be followed wherever due to unavoidable circumstances or urgencies, consignment of oxygen cylinders, ISO containers or PSA plants or its related equipment have already arrived in India, without taking import permission from PESO. The filling permission for these cylinders will be issued based on the following relaxation in the rules. Same procedure will apply for import of further such equipment in case the online approvals have not been taken.
As such, Certification of PESO will not be mandatory pre-shipment. However, the certification of PESO will be required before use of the oxygen cylinders which entails weight and hydro testing. The Indian Missions should however ensure that the oxygen cylinders should comply with India or International standards before shipment. In case of filled cylinders, the agency exporting to India shall certify that the oxygen filled in the cylinder is of such purity and concentration that is fit for medical use. The certification shall be attested by the Indian Mission in the exporting country. Further, soon upon receipt in India, such filled cylinders shall be inspected on sample basis by an empanelled agency of PESO and certified as fit for medical use.
All the filled cylinders must be verified for quality of gas filled therein under the supervision of medical/ Food and Drugs Controllers and if quality of gas conforms to their requirement of medical oxygen, cylinder may be sent directly to hospitals for use. On emptying out the oxygen, cylinder shall be sent to filler and the process as given above shall be followed.
Guidelines for PSA installations at hospitals with filling facility or at COVID centers:
A. PSA plants where generated oxygen is directly supplied to hospital/ no filling of cylinder is taking place; does not need any permission or license under rules administered by PESO and can be allowed.
B. If PSA is attached with a compressor and filling of oxygen cylinder is to take place, hospital must notify it to PESO with following information:
a. Number of filling points.
b. Number of cylinders to be stored at site
c. An SRV shall be mandatorily installed in the pipeline outlet to compressor.
d. Well ventilated location with adequate illumination.
e. Before filling the cylinder, shall be examined/ cleaned for absence of any Carbonaceous grease and valid hydro test certificate (tested cylinder at 225 Kg/Cm2 hydrostatically)
f. Filling operation shall be carried out under supervision of a competent & experienced person.
g. The space for filling of cylinders to be isolated and maintain clearance of 1m from filling point on all the sides.
C. Any COVID centre may utilize liquid cylinders on board with vaporizer for supplying of gaseous medical oxygen through pipeline or for filling cylinders in open places are permitted subject to conditions stipulated under Sr No. (B) above for PSA and information be submitted to PESO.
These relaxations shall be valid for a period of 6 months or till further orders of Department for Promotion of Industry and Internal Trade, whichever is earlier
RESOLUTION OF PENDING ISSUES OF EXPORTERS WOULD GIVE IMPETUS TO TRADE, SAYS EEPC INDIA CHAIRMAN
The value of engineering goods shipments registered a year-on-year growth of 238.27% during April, 2021 owing primarily to lower base effect and strong demand from traditional markets. This shows recovery in external trade is very much on track and improved trade outlook, said EEPC India Chairman Mahesh Desai.
“As vaccine coverage rises in Europe and North America we see further increase in demand. Shipments to China have already been quite healthy and we expect the trend to continue,” he noted.
As per data released by the government, India’s overall merchandise exports in April 2021 was US$ 30.63 billion, a jump of 195.72% over US$10.36 billion in April 2020. As compared to April 2019, exports in April 2021 exhibited a positive growth of 17.62%.
Mr Desai said that the recent surge in Covid cases has some downside risks to the growth as various state governments have imposed lockdowns and curfews to contain the spread of the virus.
“This has caused a slowdown in inter-state movement of goods and shortage of manpower. In order to address this, we urge the government to classify the export sector as the essential services,” he said.
The EEPC Chairman noted that the government has largely taken a very balanced approach to deal with the health crisis focussing both on saving lives and protecting livelihood.
In a very encouraging development, Department of Commerce has taken up various issues of exporters with the Finance Ministry for their early resolution. Some of the pending issues pertain to Remission of Duties and Taxes on Export Products (RoDTEP), Merchandise Exports from India Scheme (MEIS) and Inverted duty structure.
“Once resolved, it will further provide impetus to the export sector,” said Mr Desai.
Given the growth trends in previous fiscal and April this year, it is hoped that merchandise exports could touch $400 billion in FY22. The value of exports in the first week of May was up by almost 9% (over the same period last year) pointing to a positive trend, the EEPC Chairman concluded.
RBI SUPPORTS MEASURES TO HELP SMALL BUSINESSES HIT BY SECOND PANDEMIC WAVE
Besides providing liquidity support to small borrowers, the measures announced by RBI would boost confidence of the trade and business, said Desai.
“Over the last few months, India’s merchandise exports have shown an upward trend but the surge in new Covid cases has posed some downside risks. The relief measures announced by RBI for MSMEs should mitigate those risks,“ he added.
One of the key focus areas of the central bank was facilitating easy credit for entities in the health sector including vaccine manufacturers and suppliers of oxygen and ventilators. For this, an on-tap liquidity window of Rs 50,000 crore has been announced. This will help strengthen Covid infrastructure in the country and ensure that the impact of the second wave of the infection on the economy is minimal.
Another key support measure announced by the RBI was Resolution Framework 2.0 for Covid related stressed assets of individuals, small businesses and MSMEs. This is a major relief for small and medium players, noted Desai.
Among other things, the Production Linked Incentive (PLI) worth Rs 6,238 crore for air conditioners and LED lights would certainly give a big boost to local manufacturing. The various PLI schemes are being seen as the mega policy plan of the government to make India a global manufacturing hub, said Desai.
He noted that the PLI schemes were also being considered one of the major pull factors for MNCs looking to diversify their supply chains “This will not only bring fresh investments into the country but also offer opportunities for local firms to enter into technical tie-up and form joint ventures,” he said.
The government has so far cleared nine PLI schemes for different sectors. Both local and foreign players have shown keen interest in the scheme. Overall, an outlay of Rs 1.97 lakh crore has been lined up for 13 key sectors. All the schemes together are projected to boost India’s output by over US$ 500 billion in the next five years.
The additional manufacturing capacity coming under the PLI scheme would have a huge multiplier effect and help build a robust supply chain network linked with global giants. It will positively impact the SME sector and spur growth and employment, said Mr Desai applauding the policy action.
INDIA’S TRADE PRFORMANCE CONTINUES TO BE IMPRESSIVE IN APRIL 2021
Merchandise exports accelerate by an impressive 195.72 per cent over April 2020 levels and 17.62 per cent over the April 2019 levels.
India’s export performance continues to be impressive in April 2021 with merchandise exports accelerating by an impressive 195.72 per cent over April 2020 levels and 17.62 per cent over the April 2019 levels.
Merchandise export, excluding POL and Gems & Jewellery, have increased by 160.24% in April 2021 over the same period of 2020-21 and by 20.47% over same period of 2019-20.
The Economic recovery is also visible in the rising import growth of 167.05 per cent and 7.87 per cent during April 2021 over same period of 2020-21 and 2019-20 respectively.
Service exports estimated for April 2021* are USD 21.17 Billion, registering a positive growth of 28.68 percent vis-à-vis April 2020. The estimated value of services import for April 2021* is USD 13.00 Billion, registering a positive growth of 39.75 percent vis-à-vis April 2020. The estimated value of Net of services export for April 2021* is USD 8.17 Billion registering a positive growth of 14.28 percent vis-à-vis April 2020.
COMMODITY-WISE GROWTH TRENDS
The commodities/commodity groups which have recorded positive growth during April 2021 vis-à-vis April 2020 are Gems & jewellery (9271.21%), Jute mfg. including floor covering (1684.62%), Carpet (1352.68%), Handicrafts excl. handmade carpet (1275.46%), Leather & leather products (1201.44%), RMG of all textiles (927.08%), Cotton yarn/fabs./made-ups, handloom products etc. (618.26%), Man-made yarn/fabs./made-ups etc. (587.01%), Other cereals (451.39%), Ceramic products & glassware (444.45%), Electronic goods (372.62%), Oil meals (279.49%), Cashew (260.48%), Mica, Coal & other ores, minerals including processed minerals (241.21%), Engineering goods (238.27%), Petroleum products (191.53%), Tobacco (187.4%), Cereal preparations & miscellaneous processed items (174.61%), Iron ore (172.16%), Oil seeds (169.04%), Meat, dairy & poultry products (148.81%), Tea (146.31%), Marine products (107.94%), Spices (97.56%), Coffee (75.02%), Organic & inorganic chemicals (68.54%), Rice (61.64%), Plastic & Linoleum (51.89%), Fruits & vegetables (25.4%) and Drugs & pharmaceuticals (23.43%).
Iron Ore and Drugs & Pharmaceuticals exports have been consistently growing throughout 2020-2021 and April 2021. Rice export has been consistently growing during 2020-2021 and April 2021 except for the month of April 2020. Cereal preparations & miscellaneous processed items, Other Cereals and Oil Meals exports have been consistently growing since June 2020. Jute Mfg. including Floor Covering and Carpet exports have been consistently growing since July 2020. Handicrafts, excl. handmade carpet, Cotton Yarn/Fabs./made-ups, Handloom Products etc., Ceramic products & glassware, spices and ‘others’ categories exports are growing consistently since September 2020. Mica, Coal & Other Ores, Minerals including processed minerals export is consistently growing since October 2020.
Sectors such as Leather & leather products, Man-made Yarn/Fabs./made-ups etc., and Marine products which had been exhibiting negative growth during the pandemic (2020-2021) have picked up from March 2021 onwards.
*Note: The latest data for services sector released by RBI is for March 2021. The data for April 2021 is estimates, which may undergo revision with subsequent releases of RBI.
Commerce Minister Piyush Goyal had a virtual meeting with Ambassador Kathleen Tai, US Trade Representative on 14th May 2021. The meeting focused on increasing vaccine availability in an inclusive and equitable manner to combat the global pandemic caused by Covid-19. The proposal of India on waiver of certain TRIPS provisions to increase global vaccine production in order to take on the challenge of vaccinating the poorest of the poor and save lives was also discussed. The Minister thanked the USTR for the US announcing its support for India’s proposal. The Minister mentioned the supply chains for the vaccine manufacturers must be kept open and unbridled as the entire world is in dire need of vaccines. Both sides agreed to work towards the common resolve of increasing vaccine availability and saving lives.
GOYAL LAUNCHES ‘DGFT TRADE FACILITATION APP’ FOR PROVIDING INSTANT ACCESS TO EXPORTERS/IMPORTERS ANYTIME, ANYWHERE
Commerce & Industry Minister Piyush Goyal says that the trade facilitation app is ready for Industry 4.0.
Commerce & Industry Minister Piyush Goyal recently launched DGFT ‘Trade Facilitation’ Mobile Application, for promoting ease of doing business and providing quick access to information to importers/exporters.
Speaking about the app, Goyal said that in the post-covid world, tech-enabled governance will play a key role in determining India’s growth and competitiveness. He said that a Single-window approach has enabled tech transformation of service delivery in India. It has liberated last-mile beneficiary from location based constraints, and enhanced ease of doing business. He said that Progress in technology helps develop the economy and strengthen Indian firms in the competitive global market. “We desire to move towards paperless, automated processing systems, simple procedures for trade players, online data exchange between departments & digital payments & acknowledgements.”, he added
Lauding the initiative of DGFT, Goyal said that the new Trade Facilitation App is a step in the right direction as it provides easy, omni-channel access to various trade related processes and enquiries at the touch of button. He said that truly imbibing Prime Minister’s vision of Minimum Government, Maximum Governance, DGFT is standing up for businesses as a true leader with e-issuance of certificates, QR scan process to validate documents. It will reduce transaction cost and time for imports and exports related processes, and usher in transparency. He said that ‘Trade Facilitation Mobile App’ is a symbol of India’s Idea of Aatmanirbharta – Making governance easy, economical & accessible, as it symbolises shift in traditional thinking.
Shri Goyal said that Trade facilitation App is READY for Industry 4.0, as it provides
• Real-time trade policy updates, notifications, application status alert, tracking help requests
• Explore item-wise Export-Import policy & statistics, Track IEC Portfolio
• AI-based 24*7 assistance for trade queries
• DGFT services made accessible to all
• Your Trade Dashboard accessible anytime & anywhere
The Minister said that ‘Mobile’ India creates an international trade opportunities for MSMEs and Foreign players. It will enable creation of a quality conscious and cost-competitive domestic industry. Further, it will significantly contribute to export target of $1 Trillion by 2025 and GDP target of $5 Trillion. He said that for advanced App development, more inputs & ideas of all stakeholders should be invited for further refinement which will help in expediting our technological transformation. Shri Goyal also called for engagement with technology and language specialists to develop Governance Apps in various regional languages, which will support the spirit of oneness amongst our citizens.
The new Mobile App of DGFT provides the following features for ease of the exporters and importers –
• Real-time Trade Policy Updates and Event Notifications
• Your Trade Dashboard Anytime Anywhere
• Access all services offered by DGFT in App
• Explore Item-wise Export-Import Policy and Statistics
• 24×7 Virtual Assistance for Trade Related Queries
• Track your IEC Portfolio – IEC, Applications, Authorizations
• Real-time Alerts on status of applications
• Raise and track help requests in real-time
• Share Trade Notices, Public Notices easily
The App will be available on Android and iOS platforms. The App can also be downloaded from the DGFT Website (https://dgft.gov.in). It has been developed by the Tata Consultancy Services (TCS), as per the directions of the Directorate General of Foreign Trade (DGFT).
Opinion7 months ago
South Block’s mistakes will now be corrected by Army
Sports10 months ago
When a bodybuilder breaks Shoaib’s record
News1 year ago
PM Modi must take governance back from babus
Spiritually Speaking9 months ago
Spiritual beings having a human experience
News11 months ago
Chinese general ordered attack on Indian troops: US intel report
Sports10 months ago
West Indies avoid follow-on, England increase lead to 219
Legally Speaking12 months ago
Law relating to grant, rejection and cancellation of bail
Royally Speaking8 months ago
The young royal dedicated to the heritage of Jaipur